• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同脑区中与Tau病理相关蛋白的表达:Tau蛋白病发病机制的分子基础

Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis.

作者信息

Hu Wen, Wu Feng, Zhang Yanchong, Gong Cheng-Xin, Iqbal Khalid, Liu Fei

机构信息

Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, United States.

Key Laboratory of Neuroregeneration of Jiangsu Province and Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China.

出版信息

Front Aging Neurosci. 2017 Sep 27;9:311. doi: 10.3389/fnagi.2017.00311. eCollection 2017.

DOI:10.3389/fnagi.2017.00311
PMID:29021756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5623682/
Abstract

Microtubule-associated protein tau is hyperphosphorylated and aggregated in affected neurons in Alzheimer disease (AD) brains. The tau pathology starts from the entorhinal cortex (EC), spreads to the hippocampus and frontal and temporal cortices, and finally to all isocortex areas, but the cerebellum is spared from tau lesions. The molecular basis of differential vulnerability of different brain regions to tau pathology is not understood. In the present study, we analyzed brain regional expressions of tau and tau pathology-related proteins. We found that tau was hyperphosphorylated at multiple sites in the frontal cortex (FC), but not in the cerebellum, from AD brain. The level of tau expression in the cerebellum was about 1/4 of that seen in the frontal and temporal cortices in human brain. In the rat brain, the expression level of tau with three microtubule-binding repeats (3R-tau) was comparable in the hippocampus, EC, FC, parietal-temporal cortex (PTC), occipital-temporal cortex (OTC), striatum, thalamus, olfactory bulb (OB) and cerebellum. However, the expression level of 4R-tau was the highest in the EC and the lowest in the cerebellum. Tau phosphatases, kinases, microtubule-related proteins and other tau pathology-related proteins were also expressed in a region-specific manner in the rat brain. These results suggest that higher levels of tau and tau kinases in the EC and low levels of these proteins in the cerebellum may accounts for the vulnerability and resistance of these representative brain regions to the development of tau pathology, respectively. The present study provides the regional expression profiles of tau and tau pathology-related proteins in the brain, which may help understand the brain regional vulnerability to tau pathology in neurodegenerative tauopathies.

摘要

微管相关蛋白tau在阿尔茨海默病(AD)患者大脑中受影响的神经元内发生过度磷酸化并聚集。tau病理改变始于内嗅皮质(EC),扩散至海马体以及额叶和颞叶皮质,最终累及所有同型皮质区域,但小脑未出现tau病变。不同脑区对tau病理改变易感性不同的分子基础尚不清楚。在本研究中,我们分析了tau及与tau病理相关蛋白在脑区的表达情况。我们发现,来自AD患者大脑的额叶皮质(FC)中tau在多个位点发生过度磷酸化,而小脑中则未出现这种情况。人脑中tau在小脑的表达水平约为额叶和颞叶皮质的1/4。在大鼠脑中,具有三个微管结合重复序列(3R-tau)的tau表达水平在海马体、EC、FC、顶颞叶皮质(PTC)、枕颞叶皮质(OTC)、纹状体、丘脑、嗅球(OB)和小脑中相当。然而,4R-tau的表达水平在EC中最高,在小脑中最低。tau磷酸酶、激酶、微管相关蛋白及其他与tau病理相关的蛋白在大鼠脑中也呈区域特异性表达。这些结果表明,EC中较高水平的tau和tau激酶以及小脑中这些蛋白的低水平可能分别解释了这些代表性脑区对tau病理发展的易感性和抗性。本研究提供了脑中tau及与tau病理相关蛋白的区域表达谱,这可能有助于理解神经退行性tau病中脑区对tau病理的易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/274ff16b9ae9/fnagi-09-00311-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/69757a6b65f1/fnagi-09-00311-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/eda4672d523d/fnagi-09-00311-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/e211f1a3f2d2/fnagi-09-00311-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/399d92b138c5/fnagi-09-00311-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/22165f89a937/fnagi-09-00311-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/270656c5ed05/fnagi-09-00311-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/97300b5c4977/fnagi-09-00311-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/54ab47aeb29f/fnagi-09-00311-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/274ff16b9ae9/fnagi-09-00311-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/69757a6b65f1/fnagi-09-00311-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/eda4672d523d/fnagi-09-00311-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/e211f1a3f2d2/fnagi-09-00311-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/399d92b138c5/fnagi-09-00311-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/22165f89a937/fnagi-09-00311-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/270656c5ed05/fnagi-09-00311-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/97300b5c4977/fnagi-09-00311-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/54ab47aeb29f/fnagi-09-00311-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c0/5623682/274ff16b9ae9/fnagi-09-00311-g0009.jpg

相似文献

1
Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis.不同脑区中与Tau病理相关蛋白的表达:Tau蛋白病发病机制的分子基础
Front Aging Neurosci. 2017 Sep 27;9:311. doi: 10.3389/fnagi.2017.00311. eCollection 2017.
2
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.阿尔茨海默病早、晚期tau 病理学相关脑区的蛋白质组学特征。
Neurobiol Dis. 2019 Oct;130:104509. doi: 10.1016/j.nbd.2019.104509. Epub 2019 Jun 15.
3
Signature tau neuropathology in gray and white matter of corticobasal degeneration.皮质基底节变性灰白质中的特征性tau神经病理学改变。
Am J Pathol. 2002 Jun;160(6):2045-53. doi: 10.1016/S0002-9440(10)61154-6.
4
β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration.β-淀粉样前体蛋白和tau 蛋白水平在人类小脑与易受阿尔茨海默病型神经退行性变影响的脑区相比存在不同的调节。
Neurosci Lett. 2010 Nov 26;485(3):162-6. doi: 10.1016/j.neulet.2010.08.088. Epub 2010 Sep 6.
5
Expression of tau and phosphorylated tau in the brain of normal and hemiparkinsonian rhesus macaques.tau 和磷酸化 tau 在正常和偏侧帕金森病恒河猴大脑中的表达。
J Comp Neurol. 2023 Aug;531(11):1198-1216. doi: 10.1002/cne.25490. Epub 2023 Apr 26.
6
The big tau splice isoform resists Alzheimer's-related pathological changes.大tau剪接异构体可抵抗与阿尔茨海默病相关的病理变化。
bioRxiv. 2024 Jul 31:2024.07.30.605685. doi: 10.1101/2024.07.30.605685.
7
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks.阿尔茨海默病中tau病理分布与认知相关功能性脑网络的对应关系存在差异。
Front Neurosci. 2017 Mar 31;11:167. doi: 10.3389/fnins.2017.00167. eCollection 2017.
8
Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.人类免疫缺陷病毒阴性阿片类药物滥用者大脑中加速出现与阿尔茨海默病相关变化的易感性。
Brain. 2010 Dec;133(Pt 12):3685-98. doi: 10.1093/brain/awq263.
9
Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.在蓝斑(LC)注射合成tau原纤维后,PS19 tau转基因小鼠中tau病理的传播由LC的传入和传出连接决定。
Acta Neuropathol. 2015 Sep;130(3):349-62. doi: 10.1007/s00401-015-1458-4. Epub 2015 Jul 7.
10
Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau .来自阿尔茨海默病大脑的病理性tau蛋白诱导tau蛋白位点特异性过度磷酸化以及对SDS和还原剂具有抗性的聚集。
Front Aging Neurosci. 2019 Mar 5;11:34. doi: 10.3389/fnagi.2019.00034. eCollection 2019.

引用本文的文献

1
Divergent actions of physiological and pathological amyloid-β on synapses in live human brain slice cultures.生理和病理β-淀粉样蛋白对活人脑切片培养物中突触的不同作用。
Nat Commun. 2025 Apr 30;16(1):3753. doi: 10.1038/s41467-025-58879-z.
2
Impact of Peptide Transport and Memory Function in the Brain.脑内肽类转运与记忆功能的关系
Nutrients. 2024 Sep 2;16(17):2947. doi: 10.3390/nu16172947.
3
Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone.定量三维组织化学显示抗糖尿病药物奈格列净可使特定区域的β-淀粉样蛋白减少。

本文引用的文献

1
Glial contributions to neurodegeneration in tauopathies.胶质细胞在tau蛋白病神经退行性变中的作用。
Mol Neurodegener. 2017 Jun 29;12(1):50. doi: 10.1186/s13024-017-0192-x.
2
Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.反式作用应答DNA结合蛋白43(TDP-43)调节tau外显子10的可变剪接:对tau蛋白病发病机制的影响。
J Biol Chem. 2017 Jun 23;292(25):10600-10612. doi: 10.1074/jbc.M117.783498. Epub 2017 May 9.
3
TDP-43 suppresses tau expression via promoting its mRNA instability.
bioRxiv. 2024 Aug 17:2024.08.15.608042. doi: 10.1101/2024.08.15.608042.
4
Sleep deprivation soon after recovery from synthetic torpor enhances tau protein dephosphorylation in the rat brain.苏醒后不久的睡眠剥夺可增强大鼠大脑中 tau 蛋白的去磷酸化。
J Comp Physiol B. 2024 Jun;194(3):347-368. doi: 10.1007/s00360-023-01516-2. Epub 2023 Oct 9.
5
The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment.阿尔茨海默病中的线粒体蛋白 TSPO:与 AD 病理严重程度和神经炎症环境的关系。
J Neuroinflammation. 2023 Aug 14;20(1):186. doi: 10.1186/s12974-023-02869-9.
6
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells.针对与tau蛋白相关的神经退行性疾病的疗法:靶向分子、突触和细胞。
Neural Regen Res. 2023 Dec;18(12):2633-2637. doi: 10.4103/1673-5374.373670.
7
Machine learning application for classification of Alzheimer's disease stages using F-flortaucipir positron emission tomography.使用 F-flortaucipir 正电子发射断层扫描进行阿尔茨海默病分期的机器学习应用。
Biomed Eng Online. 2023 Apr 29;22(1):40. doi: 10.1186/s12938-023-01107-w.
8
Mouse and Human Tau Expression in Different Brain Areas.小鼠和人类tau蛋白在不同脑区的表达
J Alzheimers Dis Rep. 2022 Nov 3;6(1):677-684. doi: 10.3233/ADR-220051. eCollection 2022.
9
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.载脂蛋白 E 位于神经退行性疾病的靶心:载脂蛋白 E 基因型在阿尔茨海默病病理学和脑部疾病中的影响。
Mol Neurodegener. 2022 Sep 24;17(1):62. doi: 10.1186/s13024-022-00566-4.
10
Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer's Disease.在阿尔茨海默病的 APP-KI NL-G-F 和 NL-NL 小鼠模型中播下人源性 tau 病理学后的病理和神经生理学结果。
Acta Neuropathol Commun. 2022 Jun 23;10(1):92. doi: 10.1186/s40478-022-01393-w.
TDP-43通过促进tau mRNA的不稳定性来抑制tau表达。
Nucleic Acids Res. 2017 Jun 2;45(10):6177-6193. doi: 10.1093/nar/gkx175.
4
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.tau 减少可预防神经元丢失,并逆转 tau 病小鼠中的病理性 tau 沉积和播散。
Sci Transl Med. 2017 Jan 25;9(374). doi: 10.1126/scitranslmed.aag0481.
5
Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer's Disease.tau蛋白病变会导致兴奋性神经元丧失、网格细胞功能障碍以及类似于早期阿尔茨海默病的空间记忆缺陷。
Neuron. 2017 Feb 8;93(3):533-541.e5. doi: 10.1016/j.neuron.2016.12.023. Epub 2017 Jan 19.
6
The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the "amyloid cascade hypothesis".APP基因中导致阿尔茨海默病的突变的发现以及“淀粉样蛋白级联假说”的形成。
FEBS J. 2017 Apr;284(7):1040-1044. doi: 10.1111/febs.14004.
7
Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.tau蛋白朊病毒株决定体内细胞病理学模式、进展速率和区域易损性
Neuron. 2016 Nov 23;92(4):796-812. doi: 10.1016/j.neuron.2016.09.055. Epub 2016 Oct 27.
8
How neuroinflammation contributes to neurodegeneration.神经炎症如何导致神经退行性变。
Science. 2016 Aug 19;353(6301):777-83. doi: 10.1126/science.aag2590.
9
The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting.探寻人类大脑中神经元和神经胶质细胞的真实数量:150年细胞计数研究综述
J Comp Neurol. 2016 Dec 15;524(18):3865-3895. doi: 10.1002/cne.24040. Epub 2016 Jun 16.
10
Hyperphosphorylation determines both the spread and the morphology of tau pathology.过度磷酸化决定了 tau 病理的扩散和形态。
Alzheimers Dement. 2016 Oct;12(10):1066-1077. doi: 10.1016/j.jalz.2016.01.014. Epub 2016 Apr 28.